Maximum Allowable Cost (MAC) Deductible Pharmacy & Therapeutics (P&T) Committee Formulary Managed Care Organization (MCO) Refill Too Soon Prior Authorization (PA) Pharmacy Benefit Manager (PBM) Utilization Management (UM) Copayment Network Pharmacy Generic Drug Rebate Tiered Formulary Preferred Drug Quantity Limits Specialty Pharmacy Coverage Determination Step Therapy Population Health Medicare Part D Medication Therapy Management (MTM) Coinsurance Medicaid Out-of- Pocket Maximum Appeals Process Cost- Effectiveness Analysis Non- Preferred Drug Drug Utilization Review (DUR) Biosimilar Maximum Allowable Cost (MAC) Deductible Pharmacy & Therapeutics (P&T) Committee Formulary Managed Care Organization (MCO) Refill Too Soon Prior Authorization (PA) Pharmacy Benefit Manager (PBM) Utilization Management (UM) Copayment Network Pharmacy Generic Drug Rebate Tiered Formulary Preferred Drug Quantity Limits Specialty Pharmacy Coverage Determination Step Therapy Population Health Medicare Part D Medication Therapy Management (MTM) Coinsurance Medicaid Out-of- Pocket Maximum Appeals Process Cost- Effectiveness Analysis Non- Preferred Drug Drug Utilization Review (DUR) Biosimilar
(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.
Maximum Allowable Cost (MAC)
Deductible
Pharmacy & Therapeutics (P&T) Committee
Formulary
Managed Care Organization (MCO)
Refill Too Soon
Prior Authorization (PA)
Pharmacy Benefit Manager (PBM)
Utilization Management (UM)
Copayment
Network Pharmacy
Generic Drug
Rebate
Tiered Formulary
Preferred Drug
Quantity Limits
Specialty Pharmacy
Coverage Determination
Step Therapy
Population Health
Medicare Part D
Medication Therapy Management (MTM)
Coinsurance
Medicaid
Out-of-Pocket Maximum
Appeals Process
Cost-Effectiveness Analysis
Non-Preferred Drug
Drug Utilization Review (DUR)
Biosimilar